These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28986638)

  • 1. Expanding horizons in complement drug discovery: challenges and emerging strategies.
    Harris CL
    Semin Immunopathol; 2018 Jan; 40(1):125-140. PubMed ID: 28986638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compendium of current complement therapeutics.
    Zelek WM; Xie L; Morgan BP; Harris CL
    Mol Immunol; 2019 Oct; 114():341-352. PubMed ID: 31446305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developments in anti-complement therapy; from disease to clinical trial.
    Harris CL; Pouw RB; Kavanagh D; Sun R; Ricklin D
    Mol Immunol; 2018 Oct; 102():89-119. PubMed ID: 30121124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement: A primer for the coming therapeutic revolution.
    Barnum SR
    Pharmacol Ther; 2017 Apr; 172():63-72. PubMed ID: 27914981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renaissance of complement therapeutics.
    Ricklin D; Mastellos DC; Reis ES; Lambris JD
    Nat Rev Nephrol; 2018 Jan; 14(1):26-47. PubMed ID: 29199277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New milestones ahead in complement-targeted therapy.
    Ricklin D; Lambris JD
    Semin Immunol; 2016 Jun; 28(3):208-22. PubMed ID: 27321574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement, a target for therapy in inflammatory and degenerative diseases.
    Morgan BP; Harris CL
    Nat Rev Drug Discov; 2015 Dec; 14(12):857-77. PubMed ID: 26493766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical promise of next-generation complement therapeutics.
    Mastellos DC; Ricklin D; Lambris JD
    Nat Rev Drug Discov; 2019 Sep; 18(9):707-729. PubMed ID: 31324874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of complement modulation.
    Wagner E; Frank MM
    Nat Rev Drug Discov; 2010 Jan; 9(1):43-56. PubMed ID: 19960015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement in clinical medicine: Clinical trials, case reports and therapy monitoring.
    Ricklin D; Barratt-Due A; Mollnes TE
    Mol Immunol; 2017 Sep; 89():10-21. PubMed ID: 28576323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease.
    de Boer ECW; van Mourik AG; Jongerius I
    Front Immunol; 2020; 11():578069. PubMed ID: 33362763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complement system in inflammatory bowel disease.
    Jain U; Otley AR; Van Limbergen J; Stadnyk AW
    Inflamm Bowel Dis; 2014 Sep; 20(9):1628-37. PubMed ID: 24831561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complement deficiencies and human diseases].
    Rosain J; Ngo S; Bordereau P; Poulain N; Roncelin S; Vieira Martins P; Dragon-Durey MA; Frémeaux-Bacchi V
    Ann Biol Clin (Paris); 2014; 72(3):271-80. PubMed ID: 24876138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying complement therapeutics to rare diseases.
    Reis ES; Mastellos DC; Yancopoulou D; Risitano AM; Ricklin D; Lambris JD
    Clin Immunol; 2015 Dec; 161(2):225-40. PubMed ID: 26341313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-targeted complement therapeutics.
    Tomlinson S; Thurman JM
    Mol Immunol; 2018 Oct; 102():120-128. PubMed ID: 30220307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The eye as a complement dysregulation hotspot.
    Clark SJ; Bishop PN
    Semin Immunopathol; 2018 Jan; 40(1):65-74. PubMed ID: 28948331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Complement and Immunotherapeutics.
    Okrój M; Volokhina E
    Front Immunol; 2021; 12():663459. PubMed ID: 33717205
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics.
    Melis JP; Strumane K; Ruuls SR; Beurskens FJ; Schuurman J; Parren PW
    Mol Immunol; 2015 Oct; 67(2 Pt A):117-30. PubMed ID: 25697848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics.
    Mohebnasab M; Eriksson O; Persson B; Sandholm K; Mohlin C; Huber-Lang M; Keating BJ; Ekdahl KN; Nilsson B
    Front Immunol; 2019; 10():2539. PubMed ID: 31787968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of host cells by complement regulators.
    Schmidt CQ; Lambris JD; Ricklin D
    Immunol Rev; 2016 Nov; 274(1):152-171. PubMed ID: 27782321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.